[Adults] {Spam? 3.04} Nuvilex, Inc.’s Diabetes Study Might Get a Bump from Medical Marij. Research

[News Release]

Nuvilex, Inc.’s Diabetes Examination Could
Get a Bump from Medical Marij. Research

In a freshly released study in the American
Journal of Medicine, there could be something in there that
helps Nuvilex, Inc. (OTCQB: N.V.L.X.) and
its medical marij. division, Medical
Marij. Sciences, Inc. work hand in hand to study
Diabetes.  Nuvilex has been immersed in a
preclinical diabetes exploration where the organization
was able to utilize its cell encapsulation technology to
essentially develop a type of
“artificial pancreas” that manipulates
blood sugar levels and removes the
need for insulin treatment.

The report named “The Impact of Marijuana Use on
Glucose, Insulin, and Insulin Resistance among U.S.
Adults” probes the blo-od
sugar-related results of cannabis use
among contributors in the National
Health and Nutrition Examination Survey from 2005 to 2010.  With an
increasing number of states allowing marij. for
medicinal intentions, examination will become
more customary on the advantages
of cannabis, and Nuvilex’s extension should be right
in the mix.

The use of research materials issued by
the auth.or is done at your own risk. You are encouraged to do your own
research before making any investment decision with respect to
the secu rity discussed herein. The author has not been rewarded by any
entity in connection with the disbursement of these
materials. You should assume that as of the date of this report
or letter, the author, possibly along with or through our owners,
affiliates, employees and/or consultants,
(cooperatively referred to as the author) has a
position in all company shares (and/or options of the shares) covered
herein that is consistent with the position set forth in our report. In
connection with PLPL, the author has taken a long position. Following the
disbursement of any report or letter, the author
plans to continue engaging in trnsactns in the secu rity covered
herein, and we may be long, short, and/or neutral at any time hereafter
regardless of our initial position and we preserve the right to procure or
trade all or part of our position at any time without notice. This practice
could end in our trading securities at any time before, during, and/or
after the disbursement of this report. Full Disclaimer
http://cs.the-spout.com/link.php?M=6588707&N=235&L=3&F=T

To stop receiving these
emails:http://cs.the-spout.com/unsubscribe.php?M=6588707&C=0a89a74737fe0ab850bde605efc11be4&L=54&N=235

100 N. 18th ST, STE 300, Philadelphia,
PA 19103  USA
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://www.polarhome.com/pipermail/adults/attachments/20130618/36dab2b8/attachment.html>